Medicine Flashcards
Moderate Sedation
drug-induced depression of consciousness
during which patients respond purposefully
to verbal commands, either alone or
accompanied by light tactile stimulation.
No interventions are required to maintain a patent airway, and spontaneous ventilation is adequate. Cardiovascular function is usually
maintained.
Deep Sedation
drug-induced depression of consciousness during which patients cannot be easily aroused but respond purposefully following repeated or painful stimulation. The ability to independently maintain
ventilatory function may be impaired.
Patients may require assistance in maintaining a patent airway, and spontaneous ventilation may
be inadequate. Cardiovascular function is usually maintained.
General Anesthesia
drug-induced loss of consciousness during which patients are not arousable, even by painful stimulation. The ability to maintain ventilation function is often impaired. Patients often require assistance in
maintaining a patent airway, and positive pressure ventilation may be required because of depressed spontaneous ventilation or drug induced depression of neuromuscular function. Cardiovascular function may be impaired.
Airway Assessment
- Dental exam (Teeth, tongue, tonsils- Brodsky)
- Maximal Incisal Opening (40mm)
- Mallampati Classification
- Mandibular protrusion
- Upper lip bite test
Mallampati Classification
Predicts difficulty of intubation
Patient seated upright, NHP, with tongue protruded w/o phonation
1: Soft palate, uvula, tonsillar pillars, fauces visable
2: Superior 2/3 of uvula, and soft palate
3. 1/3 of uvula and soft palate
4. Soft palate not visible
5. BMI
6. Neck Circumference (17in)
Upper lip bite test
Grade 1- Fully covers upper lip
Grade 2- Partially covers the upper lip
Grade 3- Cannot reach the upper lip
BMI
BMI = weight Kg/height m2
Underweight: <18.5
Normal: 18.5-24.9
Overweight: 25-29.9
Obese: 30-39.9
Morbid Obesity- >40
MET
Metabolid equivalent of tasks
1 Met = O2 consumption of 70kg 40yo male at rest.
<4 Met = Shopping, slow walking
>4 Met = Housework, climbing stairs, cycling
ASA
American Society of Anesthesiology Classification
1: Healthy patient
2: Mild systemic disease w/o limitations
3: Severe systemic disease w/limited activity but not incapacitating
4: Severe systemic disease that is constant threat to life
5: Moribund patient who is not expected to survive w/o operation
6: Organ donor
E: Emergency Surgery
NPO
Clear liquids- 2 hours
Breast milk- 4 hours
Infant formula- 6 hours
Non-human mild- 6 hours
Solids (Light meals)- 6 hours
Heavy- 8 hours
Difficult Bag Mask
Facial Hair
Edentulism
>55yoa
Snoring
MIO
Cricothyrotomy
1: Extend the head and neck, identify and immobilize the cricothyroid membrane.
2: Make a horizontal incision through the skin and cricothyroid membrane
3. Use a tracheal hook to apply caudal and outward traction on the cricoid cartilage and remove the blade
4. Insert ETT (6.0 ETT or 4 Shiley)
5. Ventilate with low pressure
6. Confirm pulmonary ventilation
Convert to tracheostomy w/72 hours (subglottic stenosis)
Pediatric airway
1-10yo: Uncuffed tube= (age/4)+4
No cricothyroidtomy less than 12 you
- Large tongue
- Large occiput
- Infant are nose breathers
- Collapsible trachea
- Large tonsils/adenoids
- Larynx is higher and anterior
- Floppy posterior epiglottis
- Cricoid ring is narrowest point
- Short trachea
- HR dependent
- Horizontal ribs and less accessory muscles
Propofol
2,6-diisoprophylphenol 1%
intravenous sedative hypnotic used for induction and maintenance of anesthesia
- MOI: GABP potentiation causing depressed reticular activating system
- Soybean oil, glycerol, egg lecithin, EDTA or sodium bisulfite
- Metabolized by liver, excreted by kidney
- Direct myocardial suppression
- Profound respiratory depressant
- Adult dose: 1-2.5mg/kg
- Peds dose: 2.5-3.5mg/kg
Ketamine
Lipid-soluble derivative of phencyclidine causing dissociative anesthesia. Separates the thalamus and limbic system placing patient in cataleptic state.
- N-methyl-D-aspartate NMDA receptor antagonist
- Metabolized in liver, some active metabolites, excerpted in kidneys
- indirectly central mediated sympathetic stim
- Pschomimetic effects- salivation, LS
- 0.2-0.5mg/kg sedation
- 3-5mg/kg IM
Midazolam
1,4 Benzodiazepine sedative hypnotic
- MOI: GABA potentiation
- metabolized by liver, excreted by kidneys
- Slight cardiopulmonary depressant
- 0.1mg/kg IV Adults
Flumazenil
Benzodiazepine receptor ligand with high affinity that is a competitive antagonist with benzos.
- Initial dose: 0.2mg IV 15s
- Repeat dose: 0.2mg every minute
- Max: 1mg
Fentanyl (Sublimaze)
Narcotic agonist-analgesics of opiate receptors (mu) that inhibit ascending pain pathways.
- Metabolized by liver, excreted by kidneys
- Analgesia and sedation
- Increased nausea and vomiting
- Depresses ventilation and bradycardia
- 2mc/kg IV
Naloxone
Competitive opioid receptor antagonist at the mu receptor
- Adult dose: 0.4 to 2mg IV (2-3min 10mg)
- Pediatric dose: 0.01mg/kg upto 0.1mg/kg
Succinylcholine
Depolarizing noncompetitive agent at the cholinergic receptor
- Muscle pain, anaphylaxis, and MH
- Pretreat with atropine
- Pseudocholinesterase deficiency
- 0.3-1mg/kg IV Intubation
- 20mg IV laryngospasm
- Contraindicated in muscular dystrophy
Rocuronium
Non-depolarizing muscle relaxant at the cholinergic receptor
- Dose: 0.6-1.2mg Kg RSI
- Reversal by sugammadex (Cyclodextrin)
Hepatitides
Chronic B/C
Inflammatory mediated active hepatocellular damage and necrosis with lobular inflammatory response
Hep B: DNA virus with insidious onset
Four phases
Immune tolerant
Immune clearance
inactive HBsAg carrier
Reactivated chronic Hep B
Vertical transmission mother to fetus, percutaneous and sexual
Vaccine- Hep B immunoglobulin
Heb C: RNA virus that progresses to chronic liver disease
Percutaneous
Chronic state develops liver cirrhosis and hepatocellular carcinoma
- Harvoni: antivirals and interferons
Alchololic liver disease
Excessive alcohol intake leading to fatty liver disease, hepatitis and cirrhosis
- 5 drinks per day for 10 year
Pathophysiology- inflammation leading to parenchyma necrosis.
Treatment:
- Alcohol cessation
- Folic acid, thiamine, and zinc nutritional support
NASH, NAFLD
Nonalcoholic fatty liver disease
-metabolic syndrome
- DM2
- TPN
- Hx of gastric bypass